Byetta 5 mcg

Exenatide 5 mg.

Pharmacology
Mechanism of Action
A glucagonlike peptide-1 (GLP-1) that mimics incretin and promotes insulin secretion, suppresses glucagon, and slows gastric emptying

Absorption
Peak plasma time: 2.1 hr
Peak plasma concentration: 211 pg/mL
AUC: 1036 pg·hr/mL

Distribution
Vd: 28.3 L

Metabolism
Proteolytic degradation following glomerular filtration

Elimination
Half-life: 2.4 hr (immediate release); 2 weeks (extended release)
Renal clearance: 9.1 L/hr
Excretion: Urine (primarily)

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Byetta 5 mcg only for the indication prescribed.

Verified References
  • FDA Feb 11, 2018
  • CDC Feb 11, 2018
  • Mayo Clinic Feb 11, 2018
  • Drugs.com accessed Feb 11, 2018
  • Medscape accessed Feb 11, 2018
  • Epocrates accessed Feb 11, 2018
  • Webmd accessed Feb 11, 2018